Multi-target kinase inhibitor 3

Compound 6i is a multi-target kinase inhibitor demonstrating potent anticancer activity. It is a research tool for investigating oncogenic signaling pathways and has shown efficacy in both in vitro cell-based assays and in vivo tumor model studies.